Responses to retinoic acid of tamoxifen-sensitive and -resistant sublines of human breast cancer cell line MCF-7.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Cancer Research

• Publication date

  1992-11-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 1423259
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Retinoid antagonism of estrogen-responsive transforming growth factor alpha and pS2 gene expression in breast carcinoma cells.

  1992cited by this paper
• Effect of retinoic acid on proliferation of estrogen-responsive transformed murine Leydig cells in serum-free culture.

  1990cited by this paper
• A third human retinoic acid receptor, hRAR-gamma.

  1989cited by this paper
• Gene regulation by steroid hormones.

  1989cited by this paper
• DNA sequences outside the receptor‐binding sites differently modulate the responsiveness of the mouse mammary tumour virus promoter to various steroid hormones.

  1988cited by this paper
• A new retinoic acid receptor identified from a hepatocellular carcinoma

  1988cited by this paper
• Retinoic acid and thyroid hormone induce gene expression through a common responsive element

  1988cited by this paper
• Identification of a second human retinoic acid receptor

  1988cited by this paper
• The steroid and thyroid hormone receptor superfamily.

  1988cited by this paper
• Gene regulation by steroid hormones.

  1987cited by this paper
• A human retinoic acid receptor which belongs to the family of nuclear receptors

  1987cited by this paper
• Identification of a receptor for the morphogen retinoic acid

  1987cited by this paper
• Oestrogen and glucocorticoid responsive elements are closely related but distinct

  1987cited by this paper
• Inhibition of human mammary carcinoma cell proliferation by retinoids and intracellular cAMP-elevating compounds.

  1987cited by this paper
• Acceptor sites on chromatin for receptor bound by estrogen versus antiestrogen in antiestrogen-sensitive and -resistant MCF-7 cells.

  1986cited by this paper
• Relation of in vitro properties to tumorigenicity for a series of sublines of the human breast cancer cell line MCF-7.

  1986cited by this paper
• Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.

  1984cited by this paper
• Preparing nuclei from cells in monolayer cultures suitable for counting and for following synchronized cells through the cell cycle.

  1984cited by this paper
• Effect of retinoic acid and 4-hydroxytamoxifen on human breast cancer cell lines.

  1984cited by this paper
• Estradiol preferentially enhances extracellular tissue plasminogen activators of MCF-7 breast cancer cells.

  1984cited by this paper
• Steroid stimulation of plasminogen activator production in a human breast cancer cell line (MCF-7).

  1983cited by this paper
• Role of retinoids in differentiation and carcinogenesis.

  1983cited by this paper
• Effects of serum and insulin on the sensitivity of the human breast cancer cell line MCF-7 to estrogen and antiestrogens.

  1981cited by this paper
• Binding of retinoids to human breast cancer cell lines and their effects on cell growth.

  1980cited by this paper
• The effects of retinoids on proliferative capacities and macromolecular synthesis in human breast cancer MCF‐7 cells

  1980cited by this paper
• Different susceptibilities of human melanoma and breast carcinoma cell lines to retinoic acid-induced growth inhibition.

  1979cited by this paper
• Quantitation of fibrinolytic activity of Syrian hamster fibroblasts using 3H-labeled fibrinogen prepared by reductive alkylation.

  1977cited by this paper
• Effect of prolactin on growth and the estrogen receptor level of human breast cancer cells (MCF-7).

  1977cited by this paper
• The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture.

  1976cited by this paper
• Estrogen receptor in a human cell line (MCF-7) from breast carcinoma.

  1973cited by this paper
• A human cell line from a pleural effusion derived from a breast carcinoma.

  1973cited by this paper

• Experimental models of endocrine responsive breast cancer: strengths, limitations, and use

  2021cites this paper
• CRABP1 and CRABP2 Protein Levels Correlate with Each Other but Do Not Correlate with Sensitivity of Breast Cancer Cells to Retinoic Acid

  2021cites this paper
• Уровни белков CRABP1 и CRABP2 не коррелируют с чувствительностью клеток рака молочной железы к ретиноевой кислоте, но коррелируют между собой, причем CRABP2 является регулятором продукции CRABP1

  2021cites this paper
• Similarities between the Yin/Yang Doctrine and Hormesis in Toxicology and Pharmacology

  2020cites this paper
• The effects of all-trans retinoic acid on estrogen receptor signaling in the estrogen-sensitive MCF/BUS subline

  2018cites this paper
• Tumor Cell-selective Synergism of TRAIL- and ATRA-induced Cytotoxicity in Breast Cancer Cells.

  2018cites this paper
• Kombinationseffekte von TRAIL und Retinoiden an Zellkulturmodellen des Mammakarzinoms und des Osteosarkoms

  2015cites this paper
• TMEM33: a new stress-inducible endoplasmic reticulum transmembrane protein and modulator of the unfolded protein response signaling

  2015cites this paper
• CRABP1 is associated with a poor prognosis in breast cancer: adding to the complexity of breast cancer cell response to retinoic acid

  2015cites this paper
• ERK/MAPK regulates ERRγ expression, transcriptional activity and receptor‐mediated tamoxifen resistance in ER+ breast cancer

  2014cites this paper
• NF-κB Signaling Is Required for XBP1 (Unspliced and Spliced)-Mediated Effects on Antiestrogen Responsiveness and Cell Fate Decisions in Breast Cancer

  2014cites this paper
• ERβ decreases breast cancer cell survival by regulating the IRE1/XBP-1 pathway

  2014cites this paper
• ERRβ splice variants differentially regulate cell cycle progression

  2014cites this paper
• Chloroquine Inhibits Autophagy to Potentiate Antiestrogen Responsiveness in ER+ Breast Cancer

  2014cites this paper
• GX15-070 (Obatoclax) Induces Apoptosis and Inhibits Cathepsin D- and L–Mediated Autophagosomal Lysis in Antiestrogen-Resistant Breast Cancer Cells

  2013cites this paper
• Hormonal Regulation of Endocrine-resistant Breast Cancer

  2013cites this paper
• GX 15-070 ( Obatoclax ) Induces Apoptosis and Inhibits Cathepsin Dand L – Mediated Autophagosomal Lysis in Antiestrogen-Resistant Breast Cancer Cells

  2013cites this paper
• Glucose-regulated protein 78 controls cross-talk between apoptosis and autophagy to determine antiestrogen responsiveness.

  2012cites this paper
• Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44+ human breast cancer cells

  2012cites this paper
• Niveaux de vitamine a (retinol et acide retinoïque) mesurés dans le sang de cordon ombilical et dévéloppement rénal des nouveau-nés

  2010cites this paper
• Anti-tumor effects of retinoids combined with trastuzumab or tamoxifen in breast cancer cells: induction of apoptosis by retinoid/trastuzumab combinations

  2010cites this paper
• Orphan nuclear receptors in breast cancer pathogenesis and therapeutic response.

  2010cites this paper
• BCL2 and CASP8 regulation by NF‐κB differentially affect mitochondrial function and cell fate in antiestrogen‐sensitive and ‐resistant breast cancer cells

  2010cites this paper
• System in Tumor Invasion

  2010cites this paper
• Beta-interferon, retinoids and tamoxifen in metastatic breast cancer: long-term follow-up of a phase II study.

  2009cites this paper
• BCL-2 family function in antiestrogen-resistant breast cancer cells

  2009cites this paper
• The nuclear factor kappa b (NFkb) plays a critical role in the development of antiestrogen resistance

  2009cites this paper
• Maintenance immunotherapy in metastatic breast cancer.

  2008cites this paper
• Advances in Brief MCF 7 / LCC 2 : A 4-Hydroxytamoxifen Resistant Human Breast Cancer Variant That Retains Sensitivity to the Steroidal Antiestrogen ICI 182 , 78 o 1

  2006cites this paper
• Trial of all-trans Retinoic Acid and Tamoxifen in Patients with Advanced Breast Cancer

  2005cites this paper
• Phase 1111 Trial of all-trans Retinoic Acid and Tamoxifen in Patients with Advanced Breast Cancer

  2005cites this paper
• Cancer Biology and Hormesis: Human Tumor Cell Lines Commonly Display Hormetic (Biphasic) Dose Responses

  2005cites this paper
• The efficacy of 9-cis retinoic acid in experimental models of cancer

  2005cites this paper
• Insulin-like Growth Factor Binding Protein 1 Expression Inhibits Insulin-like Growth Factor I Action in MCF-7 Breast Cancer Cells 1

  2005cites this paper
• All trans-retinoic acid acts synergistically with hydroxytamoxifen and transforming-growth factor beta to stimulate apoptosis in MCF-7 breast cancer cells.

  2004cites this paper
• Growth Regulation by All-trans-retinoic Acid and 27

  2003cites this paper
• Alterations in the activity and expression of serine/threonine protein phosphatases during all trans retinoic acid-induced apoptosis in breast cancer cells.

  2003cites this paper
• Human Breast-Cancer Xenografts as Models of the Human Disease

  2002cites this paper
• Resistance to tamoxifen‐induced apoptosis is associated with direct interaction between Her2/neu and cell membrane estrogen receptor in breast cancer

  2002cites this paper
• Effect of all‐trans‐Retinoic acid on the hypercoagulable state of patients with breast cancer

  2002cites this paper
• Retinoic acid metabolism.

  2001cites this paper
• Cellular and molecular pharmacology of antiestrogen action and resistance.

  2001cites this paper
• Phase I clinical trial of alitretinoin and tamoxifen in breast cancer patients: toxicity, pharmacokinetic, and biomarker evaluations.

  2001cites this paper
• Phase I C linical T rial o f A litretinoin a nd T amoxifen i n Breast C ancer P atients: T oxicity, P harmacokinetic, a nd Biomarker E valuations

  2001cites this paper
• Expression and regulation of alkaline phosphatases in human breast cancer MCF-7 cells.

  2000cites this paper
• Loss of growth inhibitory effects of retinoic acid in human breast cancer cells following long-term exposure to retinoic acid

  2000cites this paper
• Involvement of nuclear steroid/thyroid/retinoid receptors and of protein kinases in the regulation of growth and of c‐erbB and retinoic acid receptor expression in MCF‐7 breast cancer cells

  1999cites this paper
• Oestradiol regulation of the components of the plasminogen-plasmin system in MDA-MB-231 human breast cancer cells stably expressing the oestrogen receptor.

  1998cites this paper
• Minimal Residual Disease in Metastatic Breast Cancer: Treatment with IFN-β, Retinoids, and Tamoxifen

  1998cites this paper
• Phase I/II trial of all-trans retinoic acid and tamoxifen in patients with advanced breast cancer.

  1998cites this paper
• Receptor-dependent growth inhibition of human pancreatic cancer by 9-cis retinoic acid

  1997cites this paper
• Retinoic acid induced growth arrest of human breast carcinoma cells requires protein kinase C alpha expression and activity.

  1997cites this paper
• Pharmacokinetics and clinical impact of all-trans retinoic acid in metastatic breast cancer: a phase II trial

  1997cites this paper
• All-trans retinoic acid decreases susceptibility of a gastric cancer cell line to lymphokine-activated killer cytotoxicity.

  1997cites this paper
• Expression of retinoid‐responsive genes occurs in colorectal carcinoma‐derived cells irrespective of the presence of resistance to all‐trans retinoic acid

  1997cites this paper
• Retinoic acid induced growth arrest of human breast carcinoma cells requires protein kinase Cα expression and activity

  1997cites this paper
• Interferon and hormone sensitivity of endocrine-related tumors.

  1996cites this paper
• Effects of antiallergic drugs on the proliferation of estrogen-sensitive mouse Leydig cell line.

  1996cites this paper
• Retinoid receptors in human lung cancer and breast cancer.

  1996cites this paper
• Retinoic acid modulates extracellular urokinase-type plasminogen activator activity in DU-145 human prostatic carcinoma cells.

  1995cites this paper
• Cellular Biology of the Retinoids

  1995cites this paper
• Growth regulation by all-trans-retinoic acid and retinoic acid receptor messenger ribonucleic acids expression in gastric cancer cells.

  1995cites this paper
• Transcription factors 3: nuclear receptors.

  1995cites this paper
• Biphasic actions of estrogen on colon cancer cell growth: possible mediation by high- and low-affinity estrogen binding sites

  1995cites this paper
• Interferon-β, Retinoids, and Tamoxifen in the Treatment of Metastatic Breast Cancer: A Phase II Study

  1995cites this paper
• Antiproliferative and synergistic effect of interferon alpha-2a, retinoids and their association in established human cancer cell lines.

  1994cites this paper
• Benzo[a]pyrene-resistant MCF-7 human breast cancer cells. A unique aryl hydrocarbon-nonresponsive clone.

  1994cites this paper
• A survey of human breast cancer sensitivity to growth inhibition by calmodulin antagonists in tissue culture.

  1994cites this paper
• Interaction of 2,3,7,8-tetrachlorodibenzo-p-dioxin and retinoic acid in MCF-7 human breast cancer cells.

  1994cites this paper
• New chemotherapeutic agents for breast cancer

  1994cites this paper
• Plasminogen-plasmin System in Tumor Invasion

  1994cites this paper
• Progression of mouse transformed leydig-cells from estrogen-sensitive to estrogen-insensitive growth phenotype concomitant with loss of leukotriene d-4 receptor.

  1994cites this paper
• Insulin-like growth factor binding protein 1 expression inhibits insulin-like growth factor I action in MCF-7 breast cancer cells.

  1994cites this paper
• Inhibition of estrogen-induced progesterone receptor in MCF-7 human breast cancer cells by aryl hydrocarbon (Ah) receptor agonists.

  1994cites this paper
• 9-Cis retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein.

  1994cites this paper
• MCF7/LCC2: a 4-hydroxytamoxifen resistant human breast cancer variant that retains sensitivity to the steroidal antiestrogen ICI 182,780.

  1993cites this paper
• Retinoid antagonism of estrogen-responsive transforming growth factor alpha and pS2 gene expression in breast carcinoma cells.

  1992cites this paper
• Effects of differentiation‐inducing agents on maturation of human MCF‐7 breast cancer cells

  1990cites this paper